Clinical Trial Update: Effect of Candesartan in Alcoholic Liver Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

The document reports completion of a phase 1/2 clinical trial evaluating candesartan for alcoholic liver fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Liver Disease

Drugs mentioned

• Candesartan (candesartan)

Snippet

Sponsor: Yonsei University | Conditions: Alcoholic Liver Disease | Phase 1, Phase 2 | Status: COMPLETED